These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34303519)

  • 1. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing.
    Duan F; Li H; Liu W; Zhao J; Yang Z; Zhang J
    Am J Med Sci; 2021 Aug; 362(2):173-181. PubMed ID: 34303519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
    Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
    Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
    Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
    Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
    Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation].
    Chen W; Sun SG; Jiang MX; Li SS; Yuan K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXD2-AS1 Predicts Dismal Prognosis for Oral Squamous Cell Carcinoma and Regulates Cell Proliferation.
    Liang X; Chen Z; Wu G
    Cell Transplant; 2020; 29():963689720964411. PubMed ID: 33103475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.
    Liu Z; Zhou W; Lin C; Wang X; Zhang X; Zhang Y; Yang R; Chen W; Cao W
    Aging (Albany NY); 2020 Dec; 13(2):2379-2396. PubMed ID: 33318296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
    Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
    Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
    Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
    Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
    Ren W; Zhu Z; Wu L
    J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate Prognostic Value of lncRNA FOXD2-AS1 in Gastric Cancer with Helicobacter pylori Infection.
    Rajabi A; Bastani S; Maydanchi M; Tayefeh-Gholami S; Abdolahi S; Saber A; Safaralizadeh R
    J Gastrointest Cancer; 2022 Sep; 53(3):687-691. PubMed ID: 34478035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.